2023 Agenda

Northern New England MedTech Conference &

MedTech Collaborative Pitch Competition

Day 1 | Pitch Competition

November 15th, 2023

Hanover Inn, Hanover, NH

Pitch Application

3:00 - 4:00pm - Registration & Social Hour

4:00 - 4:15pm - Introductions

4:15 - 6:15pm - Live Pitch Competition

Judges Panel:

Moderator: Dan Josebachvili

CEO, Silvertree

Dan Josebachvili is the Founder and CEO of Silvertree, a simple tech solution designed for Older Adults that is built for safety and deeply rooted in human connection. Silvertree is on a mission to inspire confidence for the world’s aging population.  Dan began his career as part of the founding team at Urban Escapes, an adventure-travel company focused on getting young professionals 'out of the concrete jungle' and into the outdoors. In 2010, the company was acquired by LivingSocial, where as part of the leadership team, Dan grew the Urban Escapes footprint to over 30 markets, more than 75 employees, and hundreds of thousands of customers in under three years.  Most recently, he served as an Investor and Entrepreneur in Residence at ZX Ventures, the venture capital arm of Anheuser-Busch. In this role, Dan led the deal on the acquisition of Cutwater SpiritsDan is originally from Argentina and is a proud alumnus of Dartmouth College (BA)

Read More

Jennifer Fang

Partner, Wilson Sonsini Goodrich & Rosati

Jennifer Fang is a partner at Wilson Sonsini Goodrich & Rosati in Boston, providing counsel to startups, helping them transition to successful enterprises. She navigates legal and strategic business issues, negotiating various corporate transactions such as conversions, debt and equity financings, public offerings, and more. Her focus is on companies improving patient lives and healthcare, including gene editing, cell therapy, and other advanced fields. Recognized for her contributions, Fang received the 2022 "Best Under 40" award from NAPABA and was named a “Top Woman of Law” by Massachusetts Lawyers Weekly. She speaks on corporate topics, serves on several committees, and enjoys mentoring in her community.

Read More

Mark Hardie

Director of the Center for Private Equity and Venture Capital, Tuck School of Business at Dartmouth

Prior to joining Tuck, Mark was the Director of the Entrepreneur Innovation Center at Framingham State University. A start-up veteran with deep experience in operations leadership, Mark is also an alumni Career Coach at Harvard Business School, working closely with start-up teams, first time founders and mid-career entrepreneurs. The son of two teachers, he has taught and lectured on technology issues and entrepreneurship at Harvard, MIT, University of Virginia, Framingham State University, and University of Hartford. A Massachusetts native, Mark attended primary and secondary schools in Holyoke MA, is a graduate of both Tufts University with a B.A. in Political Science and the M.I.T. Sloan School of Management with concentrations in finance and operation. He brings extensive experience launching start-ups, driving corporate strategy and business innovation, all with a focus on Internet business models, mobile device platforms, and cloud-based B2B and B2C service businesses.

Read More

Nick Conn

CSO, Casana

As the founder and Chief Scientific Officer of Casana, Nicholas Conn is trailblazing in the world of medical devices with his toilet seat-based cardiovascular monitoring system. Nick's passion for innovation and commitment to improving patient outcomes drove him to complete his PhD in Microsystems Engineering in 2016, where he first developed the technology that would ultimately become the backbone of Casana's transformative platform. Before founding Casana, Nick was a Research Scientist at the prestigious Rochester Institute of Technology (RIT). His innovative approach to medical device development, combined with his extensive knowledge of IoT and wearable technologies, has positioned Casana as a key player in the rapidly-evolving healthcare landscape.

Read More

Michael Orrico

Managing Director, BioFab Startup Lab

Michael Orrico stands at the helm of the BioFab Startup Lab as its Managing Director. The program, initiated via a grant from the U.S. Economic Development Administration, extends a platform for budding and near-formed enterprises to transition biofabrication research towards commercial viability. With a diverse background meshing business development with technical acumen across the med-tech, biotech, and consulting sectors, Michael’s experience spans over a quarter-century. His leadership stretches across organizations and projects within tissue engineering and regenerative medicine, including pivotal roles at MIT's Cryobiology Lab, AxoGen, and Aastrom Biosciences (now Vericel). An alumnus of the Columbia Business School with an M.B.A. and holding an M.S. in biomedical and mechanical engineering from MIT, Michael's expertise is a blend of business foresight and technical proficiency.

Read More


VC & Investor Representative Attendees Include:

Screenshot 2023-09-28 at 8-46-55 PM


Pitch Sponsors:



6:00-8:00pm - Reception with Speakers, Steering Committee, & Sponsors

Day 2 | Expert Panels, Networking, and Breakout Sessions

November 16th, 2023

Hanover Inn, Hanover, NH

8:15 - 8:45am - Opening Address and Introductions

Greg Lange

CEO, Simbex | President, MedTech Collaborative

Greg Lange, president of the MedTech Collaborative and CEO of Lebanon-NH-based Simbex, will kick-off day two of the Northern New England MedTech Conference with introductions and a call to action. In addition to his leadership with Simbex and the MedTech Collaborative, his experience extends to board roles at Alice Peck Day Hospital and TruVue Analytics, and founding the Medtech Collaborative. Greg, a Masters holder from the University of Massachusetts, has a rich background in biomechanics research. He resides in Lyme, New Hampshire, enjoying reading, podcasts, and outdoor activities. His commitment to seamlessly steering companies from conception to commercialization and building robust teams and enterprises is unwavering.

Read More

Michael Orrico

Managing Director, BioFab Startup Lab

Michael Orrico stands at the helm of the BioFab Startup Lab as its Managing Director. The program, initiated via a grant from the U.S. Economic Development Administration, extends a platform for budding and near-formed enterprises to transition biofabrication research towards commercial viability. With a diverse background meshing business development with technical acumen across the med-tech, biotech, and consulting sectors, Michael’s experience spans over a quarter-century. His leadership stretches across organizations and projects within tissue engineering and regenerative medicine, including pivotal roles at MIT's Cryobiology Lab, AxoGen, and Aastrom Biosciences (now Vericel). An alumnus of the Columbia Business School with an M.B.A. and holding an M.S. in biomedical and mechanical engineering from MIT, Michael's expertise is a blend of business foresight and technical proficiency.

Read More

Next Phase Medical Devices

Co-Presenting Sponsor

Returning as a three-time presenting sponsor, NextPhase is a design, development, and manufacturing partner that helps OEMs bring low- to medium-volume complex medical devices to market.

Their 20+ years of expertise in electromechanical and single-use devices combined with our skill in LEAN manufacturing, helps us bring our customers’ requirements to life. With an emphasis on our Core Values of Customer Priority, Shop Floor Focus, Teamwork, Agility, Accountability, and Continuous Improvement, NextPhase has grown to become one of North America’s premier contract developer and manufacturer of medical devices.

We’re proud to partner with NextPhase and their commitment to serving a range of customers, from multinational OEMs to startups.

Read More

8:45 - 9:30am - MedTech Highlight Reel | Rapid Sessions

8:45 - 9:00am - Our Medical Innovation Dream Team: Medical device development requires collaboration from three main groups: clinicians to identify problems, engineers to build prototypes, and entrepreneurs to analyze markets. However, it is necessary to have cohesion in the group and a Program Developer serves as a link for all involved -acting as a catalyst to continue a project’s momentum and maintain focus by facilitating effective communication between each discipline. I will discuss the opportunities for collaboration with clinicians seeking engineering and business expertise and how to build an effective and eclectic team.

9:00 - 9:15am - Calibrating a Genuinely Human Touch with Generative AI in MedTech

9:15 - 9:30am - Wireless Power and Recharging for the Next Generation of Active Implantables: Learn about advancements in wireless power and recharging for the next generation of active implantable devices. Unlock new markets, expand your patient population, and strengthen your competitive advantage with these actionable insights.

Alessandra Bryan

Clinical Research Coordinator, IDEALab

Alessandra Bryan is the Program Developer and Project Coordinator for IDEA Lab (Innovation, Development, and Entrepreneurship in Anesthesia) and a Clinical Research Coordinator for the Department of Anesthesiology and Perioperative Medicine at Dartmouth-Hitchcock Medical Center. She oversees over 10 active IDEA Lab projects and provides structural and organizational support for clinicians interested in medical innovation. Alessandra has assisted the Founder/Director in developing a medical innovation and device development curriculum for clinicians. In addition, she acts as a link between clinicians and engineers on several prototyped devices. She has experience with product development and collaborates with business leaders. She is currently working on a prototype for an expandable endotracheal tube.

Read More

Daina Andries

Co-Founder & Head of Product, Epidaurus Health

Daina Andries is a co-founder and Head of Product at Epidaurus Health, a health tech startup in Alexandria, Virginia, focused on streamlining prior authorizations for prescription medications. Following a successful application for an SBIR Award from the National Science Foundation, Daina devoted hundreds of hours to interviewing physicians, pharmacists, administrators and health service technicians to document the prior authorization process in as much depth as possible. Daina’s research has informed the underlying architecture of Epidaurus Health’s prior authorization solution as well as electronic personal health (ePHI) data curation strategies to ensure responsible AI applications. Prior to her immersion in healthcare, Daina worked with clients in fintech as a data science consultant. Her prior experience in fintech continues to inform her perspective on the potential for new approaches to healthcare finance in the interest of improving access to innovative therapies and emergent medical technologies. Daina holds a master’s degree in information science from the University of Michigan.

Read More

Grayson Zulauf

CEO, Resonant Link

Grayson Zulauf has deep expertise in wireless power systems, specializing in wide-bandgap semiconductors for next-generation power electronics. He has held Electrical Engineering, Product Management, and Executive Leadership roles throughout his career, joining Motiv Power Systems as part of the first team to electrify commercial transportation before launching Resonant Link in 2017 with the vision to Power Health for All. Grayson holds degrees from Dartmouth College and a M.S. and Ph.D. in Electrical Engineering from Stanford University. Grayson has received multiple accolades, including the National Science Foundation Graduate Research Fellowship, Forbes 30 Under 30 Energy, and the 2022 Dial Fellowship.

Read More

9:30 - 10:00am - Networking Break

10:00 - 10:45am - How to Sell into Hospitals: Best Practices from Supply Chain, Contracting, Operations, and Finance Perspectives

Best practices from supply chain, contracting, operations, and finance perspectives.

Ilsa Webeck

Managing Director & Founder, MedTech Strategies

Ilsa, a creative thinker and process driven planner, brings over 25 years in healthcare business strategy to the table.  Through her experiences working on many product types, business models and planning processes both in start-ups and multi-nationals, she knows how to see the forest AND the trees.  This experience has contributed to the success of emerging ventures and market leaders by uncovering value for new technologies.  
She has led process and product development through her work in a wide range of therapies, product areas and company types, including DePuy Spine, a Johnson and Johnson Company, and Biogen.  Ilsa has particular experience helping companies build fact-based product and strategic plans that create value and advance organizational thinking.  She enjoys working with clients to look for simple solutions to the not-so-simple problems. 
Ilsa holds a BA in Biology from Dartmouth College and an MBA from the Tuck School of Business.  She is on the board of directors of MDG Boston (Medical Development Group), a mentor/judge for Mass Challenge, and an invited lecturer on the commercial aspects of medical product development.

Read More

Bob Phelps

Co-founder & COO, ASPI

Bob Phelps is a business growth and transformation expert with experience in medical device, life science, and high tech businesses. In his role as co-founder and COO of ASPI, Bob is responsible for guiding the team to achieve the company’s growth plan, treasury and finance, HR, IT, and quality and risk management while engaging our team members to embrace the company’s culture and values.
Bob has a unique background, having led sales, marketing, finance, business development and collaboratively managed investor relations and operations. He is an expert with commercial operations and scaling companies.
In his 20 years with Johnson & Johnson, Bob led both the finance and sales functions for the orthopedic business, where revenues tripled to $300M during that time.  He built the revenue platforms for two start-ups - BioSphere Medical (embolic device) to $50MM+ revenue and ConforMIS (patient specific knee) to $40MM revenue.  He has led the Commercial teams for robotic surgery and complex software engineering firms.
Bob has launched new medical device and biologic technologies, controlled complex supply chains, sub-contract manufacturing and operations, as well as collaborating to solve complex problems with research and engineering teams. Bob has rich experience in managing organizations’ performances to the operating plan, and the P&L, cash flows and balance sheet.

Read More

Michael Prokopis

VP, Supply Chain at The University of Texas MD Anderson Cancer Center

Michael Prokopis is currently VP, Supply Chain atThe University of Texas MD Anderson Cancer Center. A highly accomplished Supply Chain and Operations senior executive, he is known for being an agile, business athlete credited with delivering cutting-edge business results and technology solutions. Expertise includes organizational, process, and digital transformation with a focus towards managing a results-oriented P&L. Michael believes in hiring and developing a team of A+ players in the areas of Contracting, Purchasing, Data Analytics, Value Analysis, Logistics & Distribution, and Hospital Operations. In previous roles and industries including Health Care, Technology, Technology Services, Casino Gaming, Telecommunications, and more, he has utilized advanced knowledge of innovative Information Technology (e.g., Robotic Process Automation, Internet of Things, Enterprise Resource Planning, Customer Relationship Management, Warehouse Management, Logistics Management, Transportation Management, etc.) while delivering digital transformation solutions. Michael is a proud father of three amazing children, a global citizen who enjoys exploring new places/cultures, and an avid golfer.

Read More

10:45 - 11:30 - The Challenges of Delivering Care at Home

One of the most promising opportunities to improve care and lower costs is the move of care delivery to the home. An increasing number of new and established organizations are launching and scaling models to move primary, acute, and palliative care to the home. For frail and vulnerable patients, home-based care can forestall the need for more expensive care in hospitals and other institutional settings.

There are tremendous opportunities to improve care through these home-based care models, but there are significant risks and challenges to their broader adoption. Today’s panel will discuss the challenges of providing quality care within these settings, especially in rural communities and discuss available solutions to enhance patient’s experiences and outcomes.  

Moderated by: Alia Hayes, MPH

State Health Assessment-State Health Improvement Plan Manager, Chronic Disease Section, Bureau of Population Health and Community Services

Alia Hayes discovered her passion for public health in 2003 at Tufts University, earning a BA/MPH with a focus on Nutrition. Her career began as a research assistant at Tufts Friedman School, working on a project to reduce childhood obesity in rural areas across four states. She later shifted to a nutrition intervention role in assisted living and nursing home settings. Seeking change, Alia moved to teaching health to middle school students in Peabody, Massachusetts, where she revamped the health curriculum and collaborated with organizations to enhance student health protections.

In 2017, she joined the Rural Health and Primary Care Section at the NH Department of Health and Human Services. Her work involved improving care quality at Critical Access Hospitals and leading strategic planning initiatives, including the creation of a support group for working mothers. During the COVID-19 pandemic, Alia played a significant role in ensuring equity in vaccine distribution and service planning in New Hampshire.

In December 2021, Alia assumed the role of State Health Assessment and State Health Improvement Plan Manager, coordinating a major health grant for New Hampshire and managing funding for COVID-19 Health Disparities. She led a significant investment into Mobile Integrated Healthcare and Care Coordination for rural chronic disease patients.

Read More

Johanna L. Beliveau, DNP, MBA, RN

President and CEO, Visiting Nurse and Hospice for Vermont and New Hampshire

Johanna Beliveau, DN, MBA, RN is the President and Chief Executive Officer at Visiting Nurse and Hospice for Vermont and New Hampshire (VNH). She was appointed by a unanimous vote of the Board of Trustees and assumed her role in June 2018. Johanna is an experienced healthcare leader with 20 years in nursing practice.

Johanna holds a Doctorate in Nursing Practice from Yale University, a Master of Business Administration from Rosemont College, a Bachelor of Science in Nursing from Fitchburg State College, and a Lean Six-Sigma Black Belt certificate from the Thayer School of Engineering, Dartmouth College. An active member of the American Organization of Nurse Leaders, Johanna was selected as a Nurse Director fellow in 2015.

Prior to joining VNH, Johanna served in multiple roles within the Dartmouth-Hitchcock Health System, most recently as Director of Quality, Patient Safety and Compliance for Mt. Ascutney Hospital and Health Center and Associate Chief Nursing Officer at Dartmouth-Hitchcock Medical Center. Her clinical and leadership experience includes hospice and palliative care, pediatrics, home health, hospice and hospital operations, regulatory readiness, quality improvement and patient safety science. Through her career, Johanna has implemented several strategic initiatives including the development of clinical advancement models, reducing employee turnover, implementing team care behaviors, and safety behaviors for error prevention.

Read More

Stephen McCalmont

CEO & Founder at BraveHeart Wireless Inc

Stephen McCalmont is a leading executive in the computing and analytics industry. With his previous companies, he raised more than $80 million in venture capital. He has been through multiple successful IPO's and numerous successful mergers and acquisitions. Prior to BraveHeart, Mr. McCalmont founded Avior Computing, Altaworks Corporation and Net2Net Corporation. These companies provided large scale analytics solutions to the healthcare, pharmaceutical, systems management, and communications networking sectors. He has been a significant contributor to multiple other start-up companies throughout his early career; Telematics, Workstation Solutions, and CrossComm. Past customers included Unitedhealthcare, Blue Cross, Cigna, Wellpoint, Charles Schwab, IBM, Harris, AT&T, MCI, Sprint, and HP. He started his career in applied cryptography at Technical Communications Corporation. Mr. McCalmont holds multiple patents and has published numerous articles in the areas of analytics, Risk and Compliance as well as systems management.

Read More

Eric Galvin

Healthcare industry executive, investor, and board member, most recently as Chief Executive Officer of PopHealthCare and Emcara Health.

Eric has been a visionary healthcare leader working across healthcare stakeholders to improve the health and well-being of the communities he serves. He has effectively collaborated with governmental entities, including elected and appointed state and federal officials and local organizations, to enhance healthcare affordability, impact, and patient experience. Eric has served on numerous for-profit and civic boards and co-founded the 501(c)3 organization, Partners for a Healthier Connecticut, dedicated to improving outcomes and the quality of life for those with Type 2 diabetes. Before his tenure at PopHealthCare, Eric held dual roles as the EVP, Chief Growth and Medical Cost Officer of EmblemHealth and the President of ConnectiCare. His extensive executive experience also spans Blue Cross Blue Shield of South Carolina, Cigna, Andersen, and Price Waterhouse. Eric graduated from the University of Connecticut with degrees in Accounting and Management Information Systems and completed an executive education program at the University of Virginia’s Darden School of Business.

Read More

Jeff Sedlack, MD,

Medical Director, Harvard Pilgrim Health Care

Jeff Sedlack has served as the Medical Director for New Hampshire and Maine at Harvard Pilgrim Health Care /Point32Health for over 8 ½ years. A fervent advocate for healthcare improvement, Jeff is deeply involved in combating food insecurity. He credits Maine’s work on the childhood hunger conference as "transformative" in shaping his approach towards enhancing childhood nutrition in the state. Having lived in Maine for 14 years, Jeff spent his first 6 years there as a General Surgeon in Belfast. Outside of his primary role, Jeff also practiced as a trauma and acute care surgeon in Anchorage, Alaska, before the pandemic. While serving as the OR director in Alaska, he initiated a "micro-food pantry" from the office, addressing food insecurity among his group’s patients. Currently, Jeff is pursuing a Master's degree in Logistics at Northeastern. He is passionately committed to refining the logistics of health delivery for the people of New England.

Read More

11:30 - 12:15 - Lunch and Networking Breakouts

Lunch with themed networking tables!

12:15 - 1:00pm Keynote Speaker

Dean Kamen

Dean Kamen is an an engineer, businessman, industry advocate, and serial inventor with an inimitable history of turning unconventional ideas into commercial successes. He is known for his invention of the Segway and iBOT, as well as establishing BioFabUSA, a program of ARMI.

Dean will discuss the vision of ARMI and advancements in biomanufacturing and how regenerative medicine is no longer only a research pursuit.


1:15 - 3:00pm - Parallel Breakout Tracks



1:15 - 2:15pm -  Biomanufacturing Challenges & Needed Breakthroughs

This session will bring together an expert panel of bioprocessing equipment and automation suppliers, researchers, and biotech entrepreneurs to identify needed breakthroughs to overcome limitations to scale-up and mass production of cell- and tissue-based therapy products.  Then, the panel will discuss recent advances in biofabrication that have potential to expedite progress.

Moderator: Michael Orrico

Managing Director, BioFab Startup Lab

Michael Orrico stands at the helm of the BioFab Startup Lab as its Managing Director. The program, initiated via a grant from the U.S. Economic Development Administration, extends a platform for budding and near-formed enterprises to transition biofabrication research towards commercial viability. With a diverse background meshing business development with technical acumen across the med-tech, biotech, and consulting sectors, Michael’s experience spans over a quarter-century. His leadership stretches across organizations and projects within tissue engineering and regenerative medicine, including pivotal roles at MIT's Cryobiology Lab, AxoGen, and Aastrom Biosciences (now Vericel). An alumnus of the Columbia Business School with an M.B.A. and holding an M.S. in biomedical and mechanical engineering from MIT, Michael's expertise is a blend of business foresight and technical proficiency.

Read More

John Hatzis

Global Life Sciences Industry Consultant, Rockwell Automation

John has marked a decade with Rockwell Automation, bringing to the fore his mastery with Rockwell technology across a spectrum of applications within the Life Sciences domain. Collaborating with BiofabUSA, John offers consultancy on control systems tailored for novel regenerative therapies and engages with Biophorum in the transition from Big Data to Smart Data. A Chemical Engineering graduate, John earned his degree from the prestigious Worcester Polytechnic Institute.

Read More

James (Jay) Hoying

Partner and Chief Scientist at Advanced Solutions Life Sciences

Jay Hoying holds the dual positions of Partner and Chief Scientist at Advanced Solutions Life Sciences (ASLS). With an expansive career spanning over three decades in both basic and applied biological sciences, he brings specialized expertise in tissue biology, vascularization, and fabrication. At ASLS, Jay oversees a dynamic laboratory dedicated to crafting advanced, vascularized human tissue models and therapeutic solutions. Before joining the ASLS fold, he distinguished himself as the Professor and Division Chief of Cardiovascular Therapeutics at the Cardiovascular Innovation Institute (CII). Here, he honed a diverse skill set encompassing tissue fabrication, cell therapeutics, and translating academic discoveries to industrial and clinical applications. An inventive force, Dr. Hoying is the brain behind the Angiomics® vascularization technology and is credited with a multitude of patents centered around vascularized tissues and their related cell therapies. On the academic front, he secured his BA and MS in Biology and Molecular Biology from Case Western Reserve University, followed by a PhD emphasizing microcirculation in Cardiovascular Physiology from the University of Arizona. Post his degree achievements, Dr. Hoying took up the mantle as a New Investigator under the NIH Program of Excellence in Molecular Biology of the Heart and Lung (POEMB). He currently offers his expertise in reviewing grant proposals for esteemed organizations like the National Institutes of Health, Veterans Affairs, the American Heart Association, among others. Recognizing his contributions, he's been inducted as a Fellow of the American Heart Association.

Read More

Dr. Ryan Halter

Dr. Ryan Halter, Associate Professor at Dartmouth’s Thayer School of Engineering

With a strong academic background in Engineering Science and Mechanics and Biomedical Engineering from institutions like Pennsylvania State University and Dartmouth, Dr. Ryan Halter brings a plethora of expertise to his role as Associate Professor at Dartmouth’s Thayer School of Engineering. Apart from his main role, he holds the dual positions of Adjunct faculty in Dartmouth’s Computer Science Department and the Department of Surgery at Dartmouth’s Geisel School of Medicine. He's also a pivotal member of the Cancer Imaging and Radiobiology Program at the Norris Cotton Cancer Center. The foundations of his academic achievements were laid at Penn State where he secured his BS in 1999 and MS in 2001, followed by a PhD from Dartmouth in 2006. His doctoral research led to the creation of a novel electrical impedance tomography device specifically for breast cancer imaging. Post his PhD, he ventured into a two-year Post-Doctoral Fellowship at Dartmouth-Hitchcock Medical Center, funded by the Congressionally Directed Medical Research Program of the DoD, where he explored the clinical implications of electrical impedance sensing in the realm of prostate cancer detection. This laid the foundation for his research program centered around the development of technologies to sense and image the electrical properties of tissues for clinical applications.

Beyond his focus on electrical property sensing and imaging, Dr. Halter's research interests span the vast domain of medical devices. He is deeply involved in creating wearable tech, surgical devices, and innovative medical imaging techniques. The overarching goal is to empower clinicians with tools that enhance their abilities to detect, diagnose, stage, treat, and monitor patients across a spectrum of pathologies. His comprehensive research process encompasses designing devices, testing them in controlled environments, and eventually rolling them out in human feasibility trials. Complementing his academic pursuits, Dr. Halter is the visionary behind the start-up, RyTek Medical, which is dedicated to bringing the groundbreaking technologies from his lab to the market.

Read More


2:15 - 3:00pm -  Translation of Regenerative Medicine to the Clinic and Commercialization

This session will bring together clinicians along with experts in hospital administration, reimbursement, and healthcare logistics.  The panelists will discuss their challenges and successes in implementing cell- and tissue-based therapies.  They will also share how regenerative medicine will impact healthcare in the future and what is necessary to transition these potentially life-changing cures from research laboratories to health care facilities, and ultimately, deliver potential cures to patients.

Andrew Osterman

CEO & Founder, Patients Precise

Andrew Osterman stands as the visionary CEO and founder of Patients Precise, a dedicated IT solution catering to hospitals. Concurrently, his role as a dedicated reimbursement expert at ARMI BioFabUSA signifies his commitment to the regenerative medicine field. In this capacity, he is instrumental in assisting biotech startups to adeptly navigate the challenges of reimbursement, payer engagement, and strategies for clinical adoption. With a rich background including his tenure as Vice President of Strategy, Product, and Value Delivery, Andrew has etched an indelible mark in the healthcare industry.

Possessing a robust skill set that spans across management, healthcare management, and business development, Andrew also boasts a deep understanding of Agile methodologies and Healthcare Information Technology (HIT). These competencies have been pivotal in driving growth and scripting success stories for numerous healthcare organizations. Andrew's academic credentials trace back to Emory University where he secured an MBA, majoring in Strategy, Healthcare, and Marketing. This academic foundation amplifies his unwavering dedication to fostering innovation and upholding excellence in the dynamic sectors of regenerative medicine and biotech.

Read More

Moderator: Richard McFarland, MD, PhD

Chief Regulatory Officer, ARMI

Dr. Richard McFarland, holding both a Ph.D. and an MD, is the esteemed Chief Regulatory Officer of ARMI/BioFabUSA. Before his distinguished service with ARMI, he served as the Associate Director of Policy for FDA/CBER’s Office of Tissues and Advanced Therapies. He also held a similar role in its precursor, the Office of Cellular, Tissue and Gene Therapies. In these significant positions, Dr. McFarland played a central role in shaping policy related to tissue engineering, regenerative medicine, and pioneering alternatives to animal testing in the realm of regulatory decision-making.

A devoted academic, Dr. McFarland's educational journey began at the University of North Carolina at Chapel Hill, where he accomplished his B.S., Ph.D., and M.D. Following this, he honed his skills at UT Southwestern in Dallas, completing both his anatomic/clinical pathology residency and a fellowship in immunopathology. His profound expertise and dedication have been instrumental in steering the course of regenerative medicine policy and ensuring the integration of safe and innovative practices.

Read More

Zbigniew M. Szczepiorkowski, MD, PhD, FCAP

Professor of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center

Zbigniew "Ziggy" Szczepiorkowski is Professor of Pathology and Laboratory Medicine at Dartmouth-Hitchcock Medical Center and Professor of Medicine at Geisel School of Medicine. Prof. Szczepiorkowski responsibilities include Director of Transfusion Medicine Service, Cellular Therapy Center and the Transfusion Medicine Fellowship Program. He is also the Medical Director, Blood Donor Program/Apheresis and Section Chief, Clinical Pathology and Laboratory Medicine.

Prof. Szczepiorkowski is an experienced elected leader in professional societies including presidency of AABB and American Society for Apheresis (ASFA). He is presently the Chair of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Prof. Szczepiorkowski has been research fellow and instructor in pathology at Harvard Medical School. He earned a Doctor of Philosophy (PhD) focused in Medicine from Postgraduate Center of Medical Education, Warsaw, Poland and his MD from Medical University of Warsaw.

Read More

David Lewandowski

Member - ARMI Leadership Advisory Council

David Lewandowski has many years of leadership experience in the field of cell and gene therapy (CGT). He has been instrumental in bringing together the CGT community and its thought leaders to tackle the challenge of safely and effectively transporting advance therapies from the point of manufacture to the point of care. David is a member of the Leadership Advisory Council for the Advanced Regenerative Manufacturing Institute (ARMI), Past President of the International Society for Biological & Environmental Repositories (ISBER) and serves on working groups to advance cryopreservation and cold chain distribution with the Standards Coordinating Body for Regenerative Medicine (SCB) and International Society for Cell & Gene Therapy (ISCT).

Read More


1:15 - 1:30pm -  R(01) vs. ROI: A New Model for Innovation in Academic Healthcare


Alexander T Abess, MD

Practicing Anesthesiologist & Assistant Professor, Geisel School of Medicine at Dartmouth

Xan Abess is a practicing anesthesiologist at Dartmouth Hitchcock Medical Center and Assistant Professor of Anesthesiology and Perioperative Medicine at the Geisel School of Medicine at Dartmouth. He holds the role of Director of Quality & Safety for the Department of Anesthesiology and Perioperative Medicine at DHMC and is the Founder and Director of IDEA Lab (Innovation Development and Entrepreneurship in Anesthesia). Xan also serves as a clinical advisor for Simbex, leveraging his extensive clinical experience from private practice, academic medicine, to military medicine, and his entrepreneurial journey of starting a medical device company. His insights span from medical device development, fundraising, grant writing, to research and regulatory requirements, and intellectual property protections.Besides his technical knowledge, Xan is recognized for his communication skills, acting as a bridge between engineers, clinicians, and business developers. Above all, he is deeply committed to assisting others in achieving their development objectives. Drawing from his background as a US Navy Flight Surgeon, Xan earned a bachelor's degree in Biomedical Engineering from The Catholic University of America and a Doctor of Medicine degree from the Medical University of South Carolina.

Read More


1:30 - 2:15pm -  How to not give away the farm: alternatives to traditional venture

The lens of what investors are looking for, private financing trends and capital raising tips.

Moderator: Jenny Barba

Managing Partner, Features Capital 

Managing Partner, Features Capital

Jenny Barba, Founder and Managing Partner of Features Capital, is a venture investor with over twenty-three years of experience financing the growth of medical device and healthcare technology innovation. Jenny has executed over $4 billion in capital transactions across thirty lead-managed public and private equity offerings, M&A, and alternative investments. Jenny specializes in deal sourcing, portfolio construction, harvesting growth and building management teams in medical technology companies across all stages of development and a broad spectrum of diseases.

Jenny has a successful track record fundraising for shareholder value creation, and strategic planning for corporate development, market expansion, commercialization growth and exits. Jenny has a broad network of trusted relationships with senior leaders in venture capital, founders, executives, board members, innovation centers and economic development hubs.

Jenny is a member of Kauffman Fellows Class 26, Trustee of Alice Peck Day Memorial Hospital part of Dartmouth Health, Steering Committee Member of the University of Michigan Fast Forward Medical Innovation Hub and the MedTech Collaborative, guest lecturer at University of Michigan and University of Vermont, and advisor to several life sciences startup hubs, including BioUtah. Jenny received her BA in Neuroscience from Colorado College and an MBA and MHSA from the University of Michigan.

Read More

Tasneem Dohadwala, MBA

Founding Partner of Excelestar Ventures

Tasneem previously worked in financial services on the sell-side at Lehman Brothers and at Matrix Partners. As Founding Partner of Excelestar Ventures, notable investments of hers include Augmenix (acq. by Boston Scientific), nVision (acq. by Boston Scientific), Conformal Medical, Diesel Labs, Instylla, Brixton, and Altiostar Networks.

She is also a Managing Partner of Golden Seeds. Furthermore, she contributed an essay, “Women and the Workplace,” to the book, Passion & Purpose: Stories from the Best and Brightest Young Business Leaders. Tasneem holds credentials from Wellesley College and Harvard Business School.

Throughout her career, Tasneem has championed women's leadership and participation in business. From her early days as an active member of the Women of Lehman Brothers, leading as President of Wellesley College Alumnae Boston, to her current role as a Managing Director of Golden Seeds, she has consistently advocated for women. She passionately mentors and scouts for female-led companies, firmly believing that investing in women is the key to elevating more of them into leadership positions.

Outside of her professional commitments, Tasneem spends quality time with her three children and husband, often spotted at ice skating rinks, soccer fields, and speech tournaments. Additionally, she holds various esteemed positions: Vice Chair of the Board of Trustees at the Pike School, a Member on Wellesley College’s President’s Advisory Council, an Ambassador for the Wellesley College Albright Institute, Charter Member of TiE Boston, member of Brigham and Women’s Cancer Research and Care Advisory Board, member of the Phillips Academy Andover Development Board, and Head of Women’s organization of her local mosque community.

Read More

Hirak Parikh

Principal, JJDC

Hirak Parikh has been a Principal at JJDC – the venture arm of Johnson and Johnson – since 2021. Based out of the Boston Innovation Center in Cambridge, MA, he manages and initiates equity investments across MedTech in East North America for JnJ. Apart from his contributions on several boards of portfolio companies, Hirak remains actively engaged in the local venture ecosystem. Before joining JJDC, Hirak helmed the Michigan Biomedical Venture Fund as its Fund Manager, a seed-stage fund, from its establishment in 2016. Prior to his venture roles, he garnered experience in neuroscience research and product development.

Hirak boasts a PhD in Biomedical Engineering from the University of Michigan, complemented by Master’s degrees in both Electrical Engineering and Biomedical Engineering from the same institution. He pursued his Bachelor of Engineering in Electronics and Telecommunication Engineering from the University of Pune, India. When not engrossed in his professional commitments, Hirak indulges in reading, playing the guitar, experimenting with B/W photography, and training for marathons.

Read More

Heather Henyon

Founding Partner, Mindshift Capital

Heather Henyon stands as the Founding Partner of Mindshift Capital, a pioneering global venture fund dedicated to financing early-stage women-led tech ventures. Under her leadership, Mindshift Capital has extended its support to 17 startups spearheaded by 23 female trailblazers spanning 5 nations. Heather’s commitment to empowering women in the entrepreneurial landscape is further solidified through her establishment of the Women’s Angel Investor Network (WAIN), recognized as the Middle East’s premier and largest women’s angel investor collective. Beyond her ventures, Heather holds a diverse investment portfolio, championing over 100 direct and fund investments across the US, Europe, and Middle East. Commencing her career in the esteemed corridors of Wall Street, Heather's two-decade-long journey weaves a tapestry of achievements in finance, technology, and strategy, notably serving as the foundational CEO of Grameen-Jameel Microfinance Ltd.

Heather’s association with pivotal investment networks extends to her role on the Investment Committee of the Next Wave Impact Fund, her inception membership and past board roles at Dubai Angel Investors and Cairo Angels Syndicate Fund. Her board directorships encompass the Sekem Holding Group in Egypt, Shiok Meats (Singapore), Little Thinking Minds (Jordan), Wellbees (Turkey), and QiDZ (UAE). Heather's contributions to the entrepreneurial world were acknowledged as she took her seat on the Cartier Women’s Initiative MENA Jury in 2020, and earned nominations for “Investor of the Year” by Arabian Business consecutively in 2017 and 2016. An American native, Heather has embraced the Middle Eastern culture for 15 years, mastering Arabic and French. Her academic journey saw her obtaining an MBA with a specialization in Finance & Entrepreneurship from the Johnson School at Cornell University as a distinguished Park Leadership Fellow, and a BA in Economics & Political Science from Oberlin College.

Read More


2:15 - 3:00pm - Accelerators: How They Work and When to Engage

In the dynamic realm of medical and medtech device startups, timing and collaboration are key. Discover the crucial indicators that signify the right time for your burgeoning enterprise to engage with an accelerator. Experts will expound on the defining characteristics that contribute to an accelerator's success, ensuring that your innovation finds the solid ground it needs to flourish. Explore scenarios when walking away to maintain independent momentum is not just an option but a strategic advantage. Learn to identify the red flags and gain the courage to steer your startup in a direction of autonomous growth when needed. This talk is an invaluable guide for medical and medtech entrepreneurs on their journey, offering a clear perspective on when to embrace collaboration and when to confidently forge an independent path.

Moderator: Barry Schweitzer, Ph.D

Associate Director, Magnuson Center for Entrepreneurship, Dartmouth College

Barry Schweitzer, Ph.D. joined the Technology Transfer Office as Senior Business Development and Licensing Manager in 2019, after 20+ years of experience in management and leadership positions in the biotech industry. Prior to joining Dartmouth, he was a Venture Partner at Elm Street Ventures, a seed and early stage venture capital firm based in New Haven, CT, where he led investments in the life sciences.  He also served on the board of the Elm City Innovation Collaborative, an organization supported by the State of Connecticut to promote, connect, and enable New Haven’s diverse innovation ecosystem, and was an Entrepreneur in Residence at Yale University and the University of Connecticut. A serial entrepreneur,  Barry was co-founder and CEO of Glygenix Therapeutics, Inc., a gene therapy company developing treatments for orphan diseases in children, and helped to start up two Yale biotech spin-off  companies (Molecular Staging and  Protometrix, Inc., acquired by Invitrogen Corporation.) He was previously an R&D leader at Life Technologies, Inc, and a Principal at BLS Partners LLC, a management consulting firm. Prior to entering the biotechnology industry, Barry was an Assistant Professor in the Department of Chemistry at the University of Central Florida, a Leukemia Society Special Fellow in the Department of Pediatrics at Yale School of Medicine, and a post-doctoral fellow at the Memorial Sloan-Kettering Cancer Institute after receiving his Ph.D. in Pharmacology from Yale. Barry was happy to return to Dartmouth where he received his Bachelor’s degree in Biology. When he is not reading scientific publications on weekends he runs with his dogs, fly fishes or skis, and enjoys his new grandson.

Read More

Elena Brondolo, MPH, MBA, EdD

Director, Future of Healthcare Residency, The Roux Institute, Northeastern University

Elena Brondolo, MPH, MBA, EdD, is the Director of the Future of Healthcare Residency at The Roux Institute, Northeastern University. Her mission is to fast-track healthcare's future by empowering early-stage health tech innovators. With over a decade of healthcare experience, Elena fuses her passions for healthcare innovation, entrepreneurship, and leadership. Her expertise spans experiential learning, change management, and program development. Before joining The Roux Institute, Elena dedicated over four years to MaineHealth, initially in clinical implementation and later as a leader in innovation education and funding programs. She revamped program curricula, guided clinicians and researchers in commercializing their ideas, and fortified the innovation foundation of the health system. Preceding her time at MaineHealth, Elena spent four years at Columbia University Medical Center/New York Presbyterian, focusing on patient flow, behavioral medicine research, and organizational development. During her tenure, she co-founded a consulting company offering evidence-based leadership and organizational development support for academic medical research groups.Elena's people-first approach to program development and partnerships is rooted in her background in Organizational Psychology. She holds an MBA and MPH concentrating in entrepreneurship, change management, and health policy, and recently earned her EdD in Learning, Leadership, and Innovation from Northeastern University. Her doctoral research explored strategies for catalyzing healthcare innovation during the pandemic, translating these strategies into action through experiential learning for large systems.

Read More

Aidan Petrie

Healthcare Innovator, strategist and mentor.

Aidan is a founding Partner of NEMIC (New England Medical Innovation Center) and a partner in Magpie Medtech Venture Fund, with a focus on supporting early stage medical technologies realize first funding and guidance through commercialization. He is a member of Cherrystone Angels and a mentor and adviser to multiple startups. 

Aidan was the founding partner of Ximedica, now Veranex, one of the world's leading medical device developers. Ximedica integrates regulated devices with connected systems to provide the next generation of healthcare solutions. 

Aidan's passion for innovation and design has helped bring hundreds of products to market that range from simple drug compliance aids to wearable therapeutics, home monitoring products and complex surgical systems.

Read More

Lauren Bass

Executive Director, LaunchVT

Lauren Bass is the Executive Director of LaunchVT, Vermont’s flagship startup accelerator and division of the Lake Champlain Chamber. LaunchVT works with community partners to provide business acceleration programs and resources to empower Vermonters and create economic opportunity in their communities.

Prior to joining the Chamber, Lauren was a consultant at the Vermont Small Business Development Center (VtSBDC), advising clients in family business, succession, sustainability, and early-stage startup strategies. She has also been an affiliated researcher and part-time lecturer at the Family Business Institute at the University of Vermont’s Grossman School of Business.

Before settling in Stowe, Lauren lived in Hong Kong for over a decade, where she started a business with two co-founders. Sourcing initial funding for the business through a pitch competition, she learned firsthand the power of a compelling pitch and the impact it can have during every step of the startup process – from idea conception to a final signature on a shareholder’s agreement.

Lauren graduated from UVM’s Sustainable Innovation MBA, completed an MA in Gender Studies at the Chinese University of Hong Kong, and earned a BA in Economics from Boston University. When she isn’t behind her desk, she prefers to be out on fresh snow with her downhill or Nordic skis and is particularly pleased when her husband and border collies join her.

Read More

3:15 - 4:00pm - The Future of Life Sciences in NH

Hear from the leaders of the Life Sciences Industry in New Hampshire about their vision to bring awareness to and expand the Life Sciences ecosystem in the state, the birth of the state’s first ever life science association, and the work underway to address the challenges and opportunities for the industry, such as workforce and talent recruitment, increasing the state’s visibility, and how the state is working together to attract life science companies, talent and the next generation.

Andrea Hechavarria

President & CEO, NH Life Sciences

Andrea Hechavarria is President & CEO of NH Life Sciences (NHLS). This is the Granite State’s first ever life sciences association. Its arrival in New Hampshire represents an exciting new chapter in the state’s economic history. The organization will advocate to nurture, protect and grow the Granite State’s cutting edge life sciences sector and the high quality jobs it delivers.

Prior to becoming a founding member of NHLS Andrea was Vice President of Government Affairs and Chief of Staff to the CEO at Butterfly Network, a disruptive digital health company transforming ultrasound with semiconductor technology and artificial intelligence.

Prior to joining Butterfly, Andrea co-lead U.S. Federal Affairs for 3M Company with a focus on 3M’s Health Care Business. While in Washington she also was one of the first Ambassadors for the Global War on Terrorism Memorial Foundation, where she helped advocate for a Memorial to be built on the Mall in Washington, DC to honor the service and sacrifice of all who served in the Global War on Terrorism. Earlier in her career, Andrea spent nearly decade as a U.S. Senate aide. During that time she had the privilege of working for four different U.S. Senators culminating with supporting two Senators on the Environment and Public Works committee with a focus on energy, environmental and regulatory reform issues. Andrea is a proud NH native.

She enjoys advising senior business leaders and executives on engagement and communications strategies with government officials and public policy stakeholders. She holds an M.B.A. from Johns Hopkins Carey Business School and a B.A. in political science from Loyola University Maryland.

Read More

Michael Skelton

CEO, Business and Industry Association (BIA) of New Hampshire

Michael Skelton currently serves as President and CEO of the Business and Industry Association (BIA) of New Hampshire, the state's leading business advocate and statewide Chamber of Commerce. Previously, Michael served as President and CEO of the Greater Manchester Chamber, the state's largest regional Chamber of Commerce. Michael also previously served as Media Spokesmen for PSNH (now Eversource), the state largest electric utility and as VP of Government Affairs for the Greater Manchester Chamber. In total, Michael has more than 15 years of leadership experience in the Chamber of Commerce industry and brings a background in public relations, media relations, economic development, and government affairs to his roles.Michael is member of the Board of Directors of Amoskeag Industries, a member of the Board of Trustees of Manchester’s historic Palace Theatre and was appointed by Governor Sununu to serve as a Board member for the New Hampshire Housing Finance Authority. Michael lives in Bedford, NH with his wife, Emily, and their two children, Colin and Eleanor.

Read More

Marc Eichenberger

Associate Vice President and Chief Business Development and Innovation Officer, University of New Hampshire

Marc Eichenberger is the Associate Vice President and Chief Business Development and Innovation Officer at the University of New Hampshire and the Managing Director of UNHInnovation. He brings a wealth of experience in bridging the corporate and university ecosystems, intellectual property (IP) commercialization and business development.In his most recent role before joining UNH, Marc help launch venture creation company, Allied Minds. As second employee and serving as the company’s chief operating officer, over 10 years he helped grow this start-up from inception to a public company. Allied Minds commercializes IP from leading US universities, national labs and corporations. The company forms, funds and operates a portfolio of companies based on this IP with the objective of delivering attractive long-term returns to investors and stakeholders. Marc’s experiences in innovation span both life sciences and technology and cut across all functional areas. In addition to leading the company’s operations, he personally closed a number of partnerships with companies around the globe. Prior to helping found Allied Minds, Marc spent over a decade in management consulting mostly with AT Kearney. There he advised mid-size and Fortune 500 companies on a variety of strategy, operations and supply chain issues. His clients represented a spectrum of aerospace, high-technology,  services and industrial companies. Marc graduated with a Master of Business Administration from The Wharton School of Business, University of Pennsylvania and is a Chartered Financial Analyst (CFA).

Read More

Taylor Caswell

Commissioner, N.H. Department of Business and Economic Affairs

Mr. Taylor Caswell is the first commissioner of the New Hampshire Department of Business and Economic Affairs. First appointed to the position by Gov. Chris Sununu in 2017, Commissioner Caswell serves as the chief economic and marketing official for the state and oversees the state Divisions of Economic Development and Travel & Tourism Development, enabling and growing economic vitality for residents and employers in the Granite State.

In this role, Caswell has defined the narrative of New Hampshire as place where people want to live and work and where companies can grow and thrive in the state’s unique tax and opportunity climate. In collaboration with policy makers, stakeholders and business leaders, he is working to update and modernize the state’s broad infrastructure of community and economic stakeholders into a more strategic and meaningful network that will be critical to sustaining and growing New Hampshire’s economy in the next century. In 2020, Commissioner Caswell pivoted to lead state economic relief recovery efforts in the face of the coronavirus pandemic. BEA spearheaded the state’s economic recovery efforts in coordination with other state agencies and partner organizations around the state.  Caswell also co-chaired the state Economic Reopening Task Force, a bi-partisan public/private group which reviews and recommended sector operations guidance. Since September of 2020, Caswell has also served as the head of the Governor’s Office for Emergency Relief and Recovery (GOFERR), with responsibility for transparent development, deployment and management of more than $2 billion in federal COVID relief and stimulus funds to New Hampshire.

Caswell’s experience in the private sector includes structuring and funding renewable power and affordable housing development, financial services and government relations work for a Fortune 500 energy company.

Prior to joining BEA, he was the executive director of the New Hampshire Community Development Finance Authority and served as the New England regional administrator for the U.S. Housing and Urban Development, a White House-level appointment.

He grew up in Littleton, where he founded PRKR MTN trails, a community-based, 20-mile multi-use mountain bike trail network.  Commissioner Caswell remains an avid year-round outdoor enthusiast and is a regular alpine skier, mountain biker, and hiker.

Read More

Moderator: Cynthia Conde

Co-founder & Board Member, New Hampshire Life Sciences

Cindy is currently a co-founder and board member for NH Life Sciences, an industry association launched in March 2023, NH’s 1 st ever “connecting, convening, and facilitating body for the broader life sciences industry in NH.” Cindy also serves on the NH EPSCoR Council, UMass Lowell’s Chancellor’s Advisory Board, and is Co-Chair of UMass Lowell’s Industrial Advisory Board for the Francis College of Engineering, and Advisory Board member for the Biomedical Engineering department. Prior to her current roles, Cindy’s 30-year professional career spanned across the consumer products, retail, medical device, biotech/pharma, information technology, and consulting industry sectors. She spent 20 years at Sanofi and Genzyme in various roles such as CIO, Director of Operations, & Engineering. Prior to Sanofi Genzyme, Cindy was the Director of Manufacturing Operations at CR Bard Cardiovascular Division, was co-founder Hawkeye Software Systems, a start-up software development company, and held various engineering positions for both CR Bard and Polaroid Corporation earlier in her professional career. Cindy earned a B.S. in Industrial Engineering and M.S. in Manufacturing Engineering and was inducted into the Francis Academy of Distinguished Engineers in 2017.

Read More

Greg Lange

CEO, Simbex | President, MedTech Collaborative

Greg Lange, president of the MedTech Collaborative and CEO of Lebanon-NH-based Simbex, will kick-off day two of the Northern New England MedTech Conference with introductions and a call to action. In addition to his leadership with Simbex and the MedTech Collaborative, his experience extends to board roles at Alice Peck Day Hospital and TruVue Analytics, and founding the Medtech Collaborative. Greg, a Masters holder from the University of Massachusetts, has a rich background in biomechanics research. He resides in Lyme, New Hampshire, enjoying reading, podcasts, and outdoor activities. His commitment to seamlessly steering companies from conception to commercialization and building robust teams and enterprises is unwavering.

Read More

4:00 - 4:45pm - Creating a Successful Innovation Ecosystem

Moderator: Kim Rosenfield

Director of Tech Transfer, Dartmouth Office of Entrepreneurship

Kim Rosenfield, J.D. joined the Office of Entrepreneurship & Tech Transfer in 2017 and became Director of Tech Transfer in 2020. Kim has served as a strategic legal and business advisor to universities, medical centers, companies, and entrepreneurs for more than 30 years. She previously worked at MIT and Partners Healthcare Innovations in Cambridge, and served as General Counsel and Board Secretary of the Research Foundation for the State University of New York, which manages all sponsored projects and intellectual property for SUNY’s 32 research campuses, and the UAB Research Foundation. She was previously General Counsel for Stereotaxis, a NASDQ listed university spin-off medical equipment company, and VP Commercial Transactions for a NYSE pharma company. She was a co-founder and member of the management team of BioHorizons, and represented universities, start-ups, and publicly- traded companies as a Member of Mintz Levin in Boston, and before that, as Head of the IP Practice at Sirote Permutt in Birmingham, AL. Kim is a graduate of Yale College and University of Virginia School of Law. She is an avid audience member and supporter of the performing arts – especially when her kids are onstage – and is Board Chair of Camille A. Brown & Dancers. From April to November you can find her jumping into Lake Sunapee after a bike ride.

Read More

Melissa Goodwin

Senior Vice President, Innovation Lab

Melissa draws on over two decades of experience in R&D, technology, innovation, and leadership to bring new and meaningful ideas to life. She currently leads innovation and commercialization efforts at seven Innovation Institute member and subscription health systems across the country as Senior Vice President for the Innovation Lab. The Innovation Lab has brought over 22 products to market with a pipeline worth 24M (and growing). This has all been done while maintaining a 98% inventor satisfaction rate. Member systems include Avera Health, Bon Secours Mercy Health, Children's Hospital of Orange County, Franciscan Missionaries of Our Lady Health System, MultiCare Health System, and Valley Children's Health. Melissa is also a Bush Foundation Leadership Fellow, published author, and TEDx Speaker.

Read More

Michael Orrico

Managing Director, BioFab Startup Lab

Michael Orrico stands at the helm of the BioFab Startup Lab as its Managing Director. The program, initiated via a grant from the U.S. Economic Development Administration, extends a platform for budding and near-formed enterprises to transition biofabrication research towards commercial viability. With a diverse background meshing business development with technical acumen across the med-tech, biotech, and consulting sectors, Michael’s experience spans over a quarter-century. His leadership stretches across organizations and projects within tissue engineering and regenerative medicine, including pivotal roles at MIT's Cryobiology Lab, AxoGen, and Aastrom Biosciences (now Vericel). An alumnus of the Columbia Business School with an M.B.A. and holding an M.S. in biomedical and mechanical engineering from MIT, Michael's expertise is a blend of business foresight and technical proficiency.

Read More

Julie Demers

Executive Director, New Hampshire Tech Alliance

Julie Demers is currently the Executive Director of the New Hampshire Tech Alliance, a statewide technology association dedicated to supporting companies at every stage of growth and development – from startups to established leaders in the global economy. A former small business owner, Demers has also served in various roles throughout the state with the NH Sector Partnerships Initiative, the University of New Hampshire-Manchester and the Greater Manchester Chamber of Commerce. Demers has served as a member of several boards including Pinkerton Academy's Board of Trustees, the University of New Hampshire IT Advisory Board, the New Hampshire State Workforce and Innovation Board, the University of New Hampshire Paul College BIP Advisory Board, and the Currier Museum of Art Advisory Board. She was recognized in 2015 as a member of the New Hampshire Union Leader’s 40 Under Forty Class. She holds a Masters in Public Administration from the University of New Hampshire.

Read More

4:45 - 5:30pm - Closing Remarks & Networking Happy Hour